Pedro Santos1, Tiago Pimenta2, Antonio Taveira-Gomes3. 1. Faculdade de Medicina, Universidade do Porto, Porto, Portugal. 2. Faculdade de Medicina, Universidade do Porto, Porto, Portugal Assistente Hospitalar de Cirurgia Geral do Centro Hospitalar S. João, Porto, Portugal. 3. Faculdade de Medicina, Universidade do Porto, Porto, Portugal Assistente Hospitalar Graduado de Cirurgia Geral, Diretor do Serviço de Cirurgia Geral, Serviço de Cirurgia Geral do Hospital Pedro Hispano, Senhora da Hora, Portugal ataveira@med.up.pt.
Abstract
INTRODUCTION: Pheochromocytomas (PHEO) and paragangliomas (PGL) are rare neuroendocrine tumors with an estimated occurrence of 2 to 5 patients per million per year and an incidence of about 1 per 100 000 in the general population. These tumors may arise sporadically or be associated to various syndromes, namely multiple endocrine neoplasia type 2, neurofibromatosis type 1, Von Hippel-Lindau syndrome, and hereditary paraganglioma-pheochromocytoma syndromes. OBJECTIVES: This article aims to review the current epidemiology, pathogenesis, clinical presentation, and genetic aspects of syndromes associated with hereditary PHEO/PGL. METHODS: The literature research, conducted at PubMed database, included review articles, published from February 2009 to February 2014, written in English or Portuguese, using as query: "Hereditary AND Pheochromocytoma." CONCLUSION: These tumors can be part of a myriad hereditary conditions that are not yet fully understood. Nevertheless, important systemic symptoms and even fatal outcomes can occur. Knowledge of these hereditary conditions can ensure a more efficient detection, treatment, and even prevention of these neuroectodermal tumors, thus new tests and studies should be conducted.
INTRODUCTION:Pheochromocytomas (PHEO) and paragangliomas (PGL) are rare neuroendocrine tumors with an estimated occurrence of 2 to 5 patients per million per year and an incidence of about 1 per 100 000 in the general population. These tumors may arise sporadically or be associated to various syndromes, namely multiple endocrine neoplasia type 2, neurofibromatosis type 1, Von Hippel-Lindau syndrome, and hereditary paraganglioma-pheochromocytoma syndromes. OBJECTIVES: This article aims to review the current epidemiology, pathogenesis, clinical presentation, and genetic aspects of syndromes associated with hereditary PHEO/PGL. METHODS: The literature research, conducted at PubMed database, included review articles, published from February 2009 to February 2014, written in English or Portuguese, using as query: "Hereditary AND Pheochromocytoma." CONCLUSION: These tumors can be part of a myriad hereditary conditions that are not yet fully understood. Nevertheless, important systemic symptoms and even fatal outcomes can occur. Knowledge of these hereditary conditions can ensure a more efficient detection, treatment, and even prevention of these neuroectodermal tumors, thus new tests and studies should be conducted.
Authors: Svetlana O Zhikrivetskaya; Anastasiya V Snezhkina; Andrew R Zaretsky; Boris Y Alekseev; Anatoly V Pokrovsky; Alexander L Golovyuk; Nataliya V Melnikova; Oleg A Stepanov; Dmitry V Kalinin; Alexey A Moskalev; George S Krasnov; Alexey A Dmitriev; Anna V Kudryavtseva Journal: Oncotarget Date: 2017-04-11
Authors: Jin Wook Yi; Hye In Kang; Su-Jin Kim; Chan Yong Seong; Young Jun Chai; June Young Choi; Moon-Woo Seong; Kyu Eun Lee; Sung Sup Park Journal: Case Rep Endocrinol Date: 2018-04-15
Authors: Alessandra Mazzucco; Eleonora Poirè; Andrea Leporati; Matteo Chiari; Laura Moneghini; Giorgio Ghilardi; Alessandro Baisi Journal: Front Surg Date: 2021-06-18
Authors: Marcio José Concepción Zavaleta; Cristian David Armas Flórez; Cesar Joel Benites Moya; Esteban Alberto Plasencia Dueñas; Sofia Pilar Ildefonso Najarro; Kely Palomino Taype; Ricardo Durand Torres; Frederick Massucco Revoredo Journal: AACE Clin Case Rep Date: 2021-02-05